The result of decades of innovation and experience in the field of pharmaceutical testing, the DTGi Series of disintegration testers from Copley simplifies testing within R&D and QC environments. Suitable for a wide range of tablet and capsule types (e.g. plain-coated tablets, delayed-release, gelatine etc.), the DTGi tester series is an affordable range of disintegration testers that complies fully with specifications defined in Ph. Eur., USP and associated Pharmacopoeias.
With the same standard features as the other DTGi Series testers and supporting up to 2 basket rack assemblies, the DTG 200i-IS offers independent control over each test station, making it ideal for the following types of applications:
Comparing one formulation directly against another
Comparing the performance of a single formulation under different conditions
Assessing delayed release or enteric coated tablets where samples must be immersed for specified periods of time in different media
Allowing two users to run tests simultaneously
Pharmacopoeial Compliance:
Ph. Eur. 2.9.1
USP and
Number of Test Stations:
2
2
Up to 12
Independent Station Control:
Yes
Unit Dimensions (w x d x h)
515 x 473 x 657 mm
Key DTGi Series Highlights
Ph. Eur. and USP and compliant
Integrated, precision temperature control and measurement
Single-point electronic temperature calibration
Intuitive touchscreen control to simplify operation
One to four test station unit configurations, plus independent station control unit option
Extensive data reporting output options: RS 232, USB A and USB B
Adjustable stroke frequency control for accelerated or high sensitivity testing
Option to automate